| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5843422 | Pharmacological Research | 2016 | 9 Pages |
Keywords
mKATPCOX-2CPKERKRAFOGDNMDAN-methyl-d-aspartatePKCIPCPI3-KMCAOVSMCPDK1APOC3apolipoprotein C3A1ARS6KBcl-2 antagonist of cell deathNAFLDreceptor for activated C-kinaseFFACSCNF-κBEGFCNVmTORNAD+ischemic preconditioningAdenosine A1 receptorsFree fatty acidmiddle cerebral artery occlusionBaxBADcardiovascular diseaseChronic diseasesnon alcoholic fatty liver diseasecopy number variationtumor necrosis factor alphaEMTRackdiacylglycerolCVDDAGCancerVascular smooth muscle cellcancer stem cellCyclooxygenase-2epidermal growth factorTNF-αphosphatidylinositol-3-kinaserapidly accelerated fibrosarcomaMetabolismMEKOxygen glucose deprivationNAD, nicotinamide adenine dinucleotidemammalian target of rapamycinProtein kinase Cmitogen activated protein kinasecreatinine phosphokinaseextracellular signal-regulated kinasephosphoinositide-dependent kinaseEpithelial-mesenchymal transition
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Barbara Capuani, Francesca Pacifici, Donatella Pastore, Raffaele Palmirotta, Giulia Donadel, Roberto Arriga, Alfonso Bellia, Nicola Di Daniele, Paola Rogliani, Pasquale Abete, Paolo Sbraccia, Fiorella Guadagni, Davide Lauro, David (MD),